Quest Diagnostics's EBITDA per Share for the
three
months ended in Dec. 2023 was $3.50.
During the past 12 months, Quest Diagnostics's average EBITDA Per Share Growth Rate was -0.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -4.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 9.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 6.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Quest Diagnostics was 34.70% per year. The lowest was -4.70% per year. And the median was 9.30% per year.
Competitive Comparison
For the Diagnostics & Research subindustry, Quest Diagnostics's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Diagnostics 5-Year EBITDA Growth Rate Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Quest Diagnostics's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Quest Diagnostics 5-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of Quest Diagnostics's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Quest Diagnostics (Quest Diagnostics) Business Description
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DGX has been successfully added to your